The Investigation of DNA Damage Induced by Adrenaline in Human Lymphocytes in Vitro/Ispitivanja Oštećenja DNK Izazvanih Adrenalinom U Limfocitima Čoveka in Vitro

Open access


Adrenaline is a neurotransmitter and hormone that plays an important role in physiological regulatory mechanisms. The objective of this study was to assess primary DNA damage in isolated human lymphocytes exposed to adrenaline using the in vitro comet assay. Dose-response of human lymphocytes was determined at concentration range of adrenaline from 0.01 μM to 300 μM for various treatment times (1h, 2h, 4h and 24h). The obtained results showed that adrenaline induced DNA damage at concentration range from 5 μM to 300 μM after 1h, 2h and 4h of treatment. The slightest DNA damage was observed after 24 h of adrenaline treatment - only the highest concentrations of adrenaline (150 μM and 300 μM) caused increased level of DNA damage. In order to evaluate the potential contribution of reactive oxygen species (ROS) in adrenaline-induced DNA damage we used antioxidants catalase (100 IU/mL and 500 IU/mL) and quercetin (100 μM and 500 μM). Co-treatment of lymphocytes with adrenaline (300 μM) and antioxidants for 1 h, significantly reduced the quantity of DNA in the comet tails. Therefore, it can be concluded that adrenaline exhibits genotoxic effects mainly through induction of reactive oxygen species and that some of the DNA damage is repaired during the first four hours following the treatment with adrenaline.

1. Bentley PJ: Endocrine Pharmacology: Physiological Basis and Therapeutic Applications. England: Cambridge University Press; 2011, 204.

2. Röntgen P, Sablotzki A, Simm A, Silber RE, Czeslick E: Effect of catecholamines on intracellular cytokine synthesis in human monocytes. Eur Cytokine Netw 2004, 15:14-23.

3. National Toxicology Program (NTP): Toxicology and carcinogenesis studies of l-Epinephrine Hydrochloride (CAS No. 55-31-2) in F344/N rats and B6C3F1 mice (inhalation studies). Natl Toxicol Program Tech Rep Ser 1990, 380:1-205.

4. Goldstein DS, Eisenhofer G, Kopin IJ: Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 2003, 305:800-811.

5. Sherwood L: Human Physiology: From Cells to Systems. Belmont CA: Thomson Brooks/ Cole,7 th Revised; 2009, 928.

6. Gavrilovic Lj, Stojiljkovic V, Kasapovic J, Pejic S, Todorovic A, Pajović BS, Dronjak S: Chronic physical stress changes gene expression of catecholamine biosynthetic enzymes in the adrenal medulla of adult rats. Acta Vet- Beograd 2012, 62(2-3):151-169.

7. Behonick GS, Novak MJ, Nealley EW, Baskin SI: Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes). J Appl Toxicol 2001, 21 Suppl 1:S15-22.

8. Costa, VM, Silva R, Ferreira LM, Branco PS, Carvalho F, Bastos ML, Carvalho RA, Carvalho M, Remião F: Oxidation process of adrenaline in freshly isolated rat cardiomyocytes: formation of adrenochrome, quinoproteins, and GSH adduct. Chem Res Toxicol 2007, 20(8):1183-1191.

9. Liu X, Wu WK, Yu L, Sung JJ, Srivastava G, Zhang ST, Cho CH: Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway. J Cell Biochem 2008, 105(1):53-60.

10. Su F, Ouyang N, Zhu P, Ouyang N, Jia W, Gong C, Ma X, Xu H, Song E: Psychological stress induces chemoresistance in breast cancer by upregulating mdr1. Biochem Biophys Res Commun 2005, 329(3):888-897.

11. Yao H, Duan Z, Wang M, Awonuga AO, Rappolee D, Xie Y: Adrenaline induces chemoresistance in HT-29 colon adenocarcinoma cells. Cancer Genet Cytogenet 2009, 190(2):81-87.

12. McGregor, DB, Raich CG, Brown A, Edwards I, Reynolds D, West K, Willington S: Reactivity of catecholamines and related substances in mouse lymphoma L5178Y Cell assay for mutagens. Environ Mol Mutagen 1988, 11:523-544.

13. Flint MS, Baum A, Chambers WH, Jenkins FJ: Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones. Psychoneuroendocrinology 2007, 32(5):470-479.

14. Djelic N, Djelic D, Spremo-Potparevic B, Markovic B, Zivkovic L: Cytogenetic analysis of the effects of epinephrine on cultured human lymphocytes. Acta Vet- Beograd 2003, 53:113-120.

15. Djelic N, Anderson D: The effect of the antioxidant catalase on oestrogens, triiodothyronine and noradrenaline in the Comet assay. Teratog Carcinog Mutagen 2003, 23:69-81.

16. Miura T, Muraoka S, Fujimoto Y, Zhao K: DNA damage induced by catechol derivates. Chem Biol Interact 2000, 126:125-136.

17. Waris G, Ahsan H: Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006, 5:14.

18. Phillips HJ: Dye exclusion tests for cell viability. In Kruse, PF, Patterson MK, editors. Tissue Culture: Methods and Applications. New York: Academic Press; 1973, 407-408.

19. Singh NP, Mc Coy, MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988, 175:184-191.

20. Tice RR, Andrews PW, Hirai O, Singh NP: The single cell gel (SCG) assay: an electrophoretic technique for the detection of DNA damage in individual cells. Adv Exp Med Biol 1991, 283:157-164.

21. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF: Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000, 35:206-221.

22. Anderson D, Yu T-W, Phillips BJ, Schmezer P: The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the COMET assay. Mutat Res 1994, 307:261-271.

23. Collins AR: The comet assay. Principles, applications, and limitations. Methods Mol Biol 2002, 203:163-177.

24. Djelic N, Spremo-Potparevic B, Markovic B, Zivkovic L, Djelic D: Cell cycle kinetics and cytogenetic changes in human lymphocytes exposed to oestradiol in vitro. Acta Vet- Beograd 2006, 56:37-48.

25. Djelic N, Nesic I, Stanimirovic Z, Jovanovic S: Evaluation of the genotoxic effects of thyroxine using in vivo cytogenetic test on Swiss albino mice. Acta Vet- Beograd 2007, 57: 487-495.

26. Djelic N: Evaluation of mitogenic effects of oxytocin on cultured human lymphocytes. Acta Vet- Beograd 2002, 52: 19-26.

27. Tuck A, Smith S, Larcom L. Chronic lymphocytic leukemia lymphocytes lack the capacity to repair UVC-induced lesions. Mutat Res 2000, 459:73-80.

28. Roser S, Pool-Zobel BL, Rechkemmer G: Contribution of apoptosis to responses in the comet assay. Mutat Res 2001, 497(1-2):169-175.

29. Rundell MS, Wagner ED, Plewa MJ: The comet assay: genotoxic damage or nuclear fragmentation? Environ Mol Mutagen 2003, 42(2):61-67.

30. Lankoff A, Carmichael WW, Grasman KA, Yuan M: The uptake kinetics and immunotoxic effects of microcystin-LR in human and chicken peripheral blood lymphocytes in vitro. Toxicology 2004, 204(1):23-40.

31. Genova ML, Abd-Elsalam, NM, Mahdy el SM, Bernacchia A, Lucarini, M, Pedulli GF, Lenaz G: Redox cycling of adrenaline and adrenochrome catalysed by mitochondrial Complex I. Arch Biochem Biophys 2006, 447(2):167-173.

32. Miyazaki I, Asanuma M: Dopaminergic neuron-specifi c oxidative stress caused by dopamine itself. Acta Med Okayama 2008, 62:141-150.

33. Manini P, Panzella L, Napolitano A, d’Ischia M: Oxidation chemistry of norepinephrine: partitioning of the O-quinone between competing cyclization and chain breakdown pathways and their roles in melanin formation. Chem Res Toxicol 2007, 20:1549-1555.

34. Sousa RL, Marletta MA: Inhibition of cytochrome P450 activity in rat liver microsomes by the naturally occurring fl avonoid, quercetin. Arch Biochem Biophys 1985, 240: 345-357.

35. Dhalla, SN, Sasaki H, Mochizuki S, Dhalla SK, Liu X, Elimban V: Catecholamine-induced cardiomyopathy. London: Taylor and Francis, 3rd ed; 2001, 269-318.

36. Silva R, Boldt S, Costa VM, Carmo H, Carvalho M, Carvalho F, Bastos Mde L, Lemos- Amado F, Remião F: Evaluation of GSH adducts of adrenaline in biological samples. Biomed Chromatogr 2007, 21:670-9.

37. Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguez H: Free-radical-induced damage to DNA: mechanisms and measurement. Free Rad Bio Med 2002, 32:1102-15.

38. Willcox JK, Ash SL, Catignani GL: Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 2004, 44(4):275-295.

39. Remião F, Rettori D, Han D, Carvalho F, Bastos ML, Cadenas E: Leucoisoprenochromeo- semiquinone formation in freshly isolated adult rat cardiomyocytes. Chem Res Toxicol 2004, 17:1584-1590.

40. Monks TJ, Jones DC, Bai F, Lau SS: The role of metabolism in 3,4-(()- methylenedioxyamphetamine and 3,4-(()-methylenedioxymethamamphetamine (Ecstasy) toxicity. Ther Drug Monit 2004, 26:132-136.

41. Cavalieri EL, Li KM, Balu N, Saeed M, Devanesan P, Higginbotham S, Zhao J, Gross ML, Rogan EG: Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 2002, 23:1071-1077.

42. Akiyama T, Yamazaki T: Myocardial interstitial norepinephrine and dihydroxyphenylglycol levels during ischemia and reperfusion. Cardiovasc Res 2001, 49:78-85.

43. Milovanovic A, Milovanovic J, Milovanovic A, Konstatinovic Lj, Petrovic M, Kekus D, Petronijevic Vrzic S, Artiko V: Metabolism Of Biogenic Amines In Acute Cerebral Ischemia: Infl uence Of Systemic Hyperglycemia. Acta Vet- Beograd 2012, 62(4):385-401.

44. Hoffman BB: Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Goodman & Gilman‘s: the Pharmacological Basis of Therapeutics, Hardman, JG, Limbird, LE and Gilman, AG (eds). New York: McGraw-Hill; 2001, 215-268.

45. Carvalho F, Remiăo F, Amado F, Domingues P, Correia AJF and Bastos ML: d Amphetamine interaction with glutathione in freshly isolated rat hepatocytes. Chem Res Toxicol 1996, 9:1031-1036.

46. Klaunig JE, Kamendulis LM: The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004, 44:239-267.

47. Behrend L, Henderson G, Zwacka, RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 2003, 31:1441-1444.

48. Wu LL, Chiou CC, Chang PY, Wu JT: Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004, 339: 1-9.

49. Gold SM, Zakowski SG, Valdimarsdottir HB, Bovbjerg DH: Higher Beck depression scores predict delayed epinephrine recovery after acute psychological stress independent of baseline levels of stress and mood. Biol Psychol 2004, 67:261-73.

50. Wuren M, Yougang Z, Huangrong L, Banchao S, Jiefeng L, Jin Y, Changrong W, Xiaolong X, Yuying H, Xiaoxi L, Fenghua L, Jianqin X: Effect of transport stress on peripheral blood lymphocyte subsets and Th cytokines in pigs. Acta Vet- Beograd 2013, 63(2-3):177-190.

51. Cohen L, Marshall GD Jr, Cheng L, Agarwal SK, Wei Q: DNA repair capacity in healthy medical students during and after exam stress. J Behav Med 2000, 23(6):531-544.

52. Forlenza, MJ, Latimer JJ, Baum A: The effects of stress on DNA repair capacity. Psychology and Health 2000, 15:881-889.

53. Pereira B, Costa-Rosa LF, Bechara EJ, Newsholme P, Curi R: Changes in the TBARs content and superoxide dismutase, catalase and glutathione peroxidase activities in the lymphoid organs and skeletal muscles of adrenodemedullated rats. Braz J Med Biol Res 1998, 31(6):827-833.

Acta Veterinaria

The Journal of University of Belgrade

Journal Information

IMPACT FACTOR 2018: 0.656
5-year IMPACT FACTOR: 0,532

CiteScore 2018: 0.71

SCImago Journal Rank (SJR) 2018: 0.281
Source Normalized Impact per Paper (SNIP) 2018: 0.547

Cited By


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 264 236 16
PDF Downloads 120 112 5